Operating income increased 70.6%
Operating income changed +70.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +70.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital / assets changed -1192 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Shares outstanding changed +308.0% from the comparable as-filed period.
Research & development changed +28.1% from the comparable as-filed period.
Stock-based compensation changed +31.3% from the comparable as-filed period.
Total assets changed +29.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed +27.7% from the comparable as-filed period.
Current liabilities changed +27.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current ratio changed -16.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed +106.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Trade receivables changed +17.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Working capital changed -17.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current assets changed +6.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Cash & equivalents changed +0.8% from the comparable as-filed period.
Noncurrent long-term debt changed +0.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Cash & equivalents changed -1.3% from the comparable as-filed period.
Stock-based compensation changed +17.4% from the comparable as-filed period.
Capital expenditure changed +13.8% from the comparable as-filed period.
Research & development changed +22.2% from the comparable as-filed period.
Operating income changed +75.5% from the comparable as-filed period.
Operating cash flow changed +53.8% from the comparable as-filed period.
Net income changed +125.2% from the comparable as-filed period.
Gross profit changed +28.1% from the comparable as-filed period.
Free-cash-flow proxy changed +65.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.